头孢哌酮/舒巴坦对老年医院获得性肺炎的疗效分析

Curative effect analysis of cefoperazone/sulbactam in the treatment of senile Hospital-acquired pneumonia

目的探讨头孢哌酮/舒巴坦对老年医院获得性肺炎(HAP)治疗效果。方法对我院收治的98例老年医院获得性肺炎患者随机分为实验组及对照组,实验组患者用头孢哌酮/舒巴坦进行治疗,对照组患者采用头孢哌酮进行治疗,治疗后对两组患者疗效以及细菌清除率进行比较。结果实验组患者的治疗效果以及致病菌的清除率明显优于对照组(P<0.05)。结论头孢哌酮/舒巴坦对老年医院获得性肺炎具有良好的治疗效果,致病菌对其耐药性低。

Objective To investigate the curative effect of cefoperazone/sulbactam in the treatment of senile Hospital-acquired pneumonia （HAP）. Methods 98 cases of senile HAP in our hospital were randomly divided into experimental group and control group, meanwhile the control group treated with cefoperazone/sulbactam and the control group were treated with cefoperazone, and then the cura- tive effect and bacterial eradication rate were compared between the two groups after treatment. Results The curative effect and bacterial eradication rate in experimental group were significantly better than those in the control group （ P 〈 0.05 ）. Conclusion cefoperazone/sulbactam in elderly hospital-acquired pneumonia with a good therapeutic effect, the low resistance of its pathogens, can effectively improve the prognosis of patients, and reduce patients＇ mortality.